ARCHIVES

In Brief: Breast Cancer coalition Plan Rally, Conference; FDA Seeks Information On Unlabeled Drug Uses

This article is from The Cancer Letter archive.

Vol. 19 No. 18 | April 30, 1993

Download PDF Visit The Full Archive

Related Articles

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

April 26, 1974

NCAB Gives Final Approval to New Guidelines for P01s

May 29, 1987

NCI’s Professional Judgment Budget Outlines Spending of $7.2 Billion

February 13, 2009

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

June 14, 2013

To Become Effective Lobbyists, Scientists Seek Alliances With Patient Advocates

March 31, 1995

DCE Concepts Statements

March 11, 1988